22nd World Congress of Neurology (WCN) -- OCT 31-NOV 05, 2015 -- Santiago, CHILEKahraman, Turhan/0000-0002-8776-0664;WOS: 000384634801394
Multiple sclerosis (MS) is an immunologically mediated disorder in which inflammation and demyelinat...
International audienceThe therapeutic arsenal for preventing multiple sclerosis (MS) relapses strong...
Introduction: Relapses of multiple sclerosis (MS) are usually treated with high-dose intravenous met...
Joint ACTRIMS-ECTRIMS Meeting -- SEP 10-13, 2014 -- Boston, MAWOS: 000354441300475…ACTRIMS, ECTRIM
Introduction: Secondary progressive multiple sclerosis (SPMS) is the phase in which disability conti...
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -...
Objectives: Multiple sclerosis is usually clinically characterized by repeated subacute relapses fol...
Abstract – Primary progressive multiple sclerosis (PPMS) is defined clinically with a progressive co...
Sixty Multiple Sclerosis patients hospitalized either in relapse (28) or in chronic progressive (32)...
Corticosteroids (Cs) are widely used for treatment of multiple sclerosis (MS) acute relapses because...
Objective - To investigate the efficacy of two different high doses of intravenous methylprednisolon...
We investigated the effect of oral and intravenous methylprednisolone treatment on subsequent relaps...
Background: Glucocorticoid treatment is recommended as the first-line treatment of MS relapses, howe...
WOS: 000275932000006Background: Glucocorticoid treatment is recommended as the first-line treatment ...
Background Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly e...
Multiple sclerosis (MS) is an immunologically mediated disorder in which inflammation and demyelinat...
International audienceThe therapeutic arsenal for preventing multiple sclerosis (MS) relapses strong...
Introduction: Relapses of multiple sclerosis (MS) are usually treated with high-dose intravenous met...
Joint ACTRIMS-ECTRIMS Meeting -- SEP 10-13, 2014 -- Boston, MAWOS: 000354441300475…ACTRIMS, ECTRIM
Introduction: Secondary progressive multiple sclerosis (SPMS) is the phase in which disability conti...
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -...
Objectives: Multiple sclerosis is usually clinically characterized by repeated subacute relapses fol...
Abstract – Primary progressive multiple sclerosis (PPMS) is defined clinically with a progressive co...
Sixty Multiple Sclerosis patients hospitalized either in relapse (28) or in chronic progressive (32)...
Corticosteroids (Cs) are widely used for treatment of multiple sclerosis (MS) acute relapses because...
Objective - To investigate the efficacy of two different high doses of intravenous methylprednisolon...
We investigated the effect of oral and intravenous methylprednisolone treatment on subsequent relaps...
Background: Glucocorticoid treatment is recommended as the first-line treatment of MS relapses, howe...
WOS: 000275932000006Background: Glucocorticoid treatment is recommended as the first-line treatment ...
Background Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly e...
Multiple sclerosis (MS) is an immunologically mediated disorder in which inflammation and demyelinat...
International audienceThe therapeutic arsenal for preventing multiple sclerosis (MS) relapses strong...
Introduction: Relapses of multiple sclerosis (MS) are usually treated with high-dose intravenous met...
DOI
Add to ORKG